Search Within

Joachim Yahalom

  1. "Ariela Noy"
Formats
  1. Meeting Abstract (36)
  2. Journal Article (32)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (71)
  2. Department of Medicine (71)
  3. Hematologic Malignancies, Division of (71)
  4. Lymphoma (71)
  5. Radiation Oncology, Department of (71)
  6. Survivorship Research (71)

More Groups

People
  1. Ariela Noy (71)
  2. Andrew Zelenetz (60)
  3. David Straus (52)
  4. Steven Horwitz (45)
  5. Paul Hamlin (44)
  6. Alison Moskowitz (38)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (8)
  4. 2022 (3)
  5. 2021 (7)
  6. 2020 (6)

More Years

Publications
  1. Blood (31)
  2. Hematological Oncology (8)
  3. Journal of Clinical Oncology (7)
  4. Blood Advances (6)
  5. British Journal of Haematology (4)
  6. Haematologica (3)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Wiley Blackwell (8)
  3. American Society of Clinical Oncology (7)
  4. Elsevier Inc. (4)
  5. John Wiley & Sons (4)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (71)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Nimer, S. D.; Portlock, C.; Straus, D.; Noy, A.; O'connor, O.; Filippa, D. A.; Teruya-Feldstein, J.; Gencarelli, A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
    Journal Article

    Straus, D. J.; Portlock, C. S.; Qin, J.; Myers, J.; Zelenetz, A. D.; Moskowitz, C.; Noy, A.; Goy, A.; Yahalom, J.
    Blood (2004)

    Fulltext@MSK | Save
  • Stanford V and radiotherapy for advanced and locally extensive Hodgkin's disease (HD): The memorial Sloan-Kettering Cancer Center (MSKCQ) experience
    Meeting Abstract

    Yahalom, J.; Edwards-Bennett, S.; Jacobs, J.; Moskowitz, C. H.; Wu, E. J.; Cotler, M.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Portlock, C. S.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Risk-adpated high dose chemoradiotherapy and ASCT for patients with relapsed and primary refractory Hodgkin's disease: An intent to treat analysis
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Rice, R. D.; Rosenzweig, L.; Horwitz, S.; Noy, A.; O'connor, O.; Portlock, C. S.; Straus, D.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Hamlin, P. A.; Zelenetz, A. D.; Kewalramani, T.; Qin, J.; Satagopan, J. M.; Verbel, D.; Noy, A.; Portlock, C. S.; Straus, D. J.; Yahalom, J.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Clone specific PCR detects clonal cells after radiation therapy for early stage gastric MALT lymphoma
    Meeting Abstract

    Noy, A.; Yahalom, J.; Zaretsky, L.; Brett, I.; Zelenetz, A. D.
    Blood (2002)

    Fulltext@MSK | Save
  • H. pylori-independent MALT lymphoma of the stomach: Excellent outcome with radiation alone
    Meeting Abstract

    Yahalom, J.; Portlock, C. S.; Gonzales, M.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Zelenetz, A. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease
    Meeting Abstract

    Straus, D. J.; Yahalom, J.; Zelenetz, A. D.; Qin, J.; Myers, J.; Moskowitz, C. H.; Noy, A.; Bertino, J. R.; Portlock, C. S.
    Blood (2001)

    Fulltext@MSK | Save
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Trippett, T.; Hedrick, E. E.; Filippa, D. A.; Louie, D.; Gonzales, M.; Walits, J.; Coady-Lyons, N.; more...
    Blood (2001)

    Fulltext@MSK | Save